» Articles » PMID: 33363164

The Involvement of the Hsa_circ_0088494-miR-876-3p-CTNNB1/CCND1 Axis in Carcinogenesis and Progression of Papillary Thyroid Carcinoma

Overview
Specialty Cell Biology
Date 2020 Dec 28
PMID 33363164
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, growing studies have demonstrated that circular RNAs (circRNAs) function as critical players in multiple human tumors, including papillary thyroid carcinoma (PTC). However, the expression and underlying potential mechanism of circRNAs in PTC are still not fully elucidated. In this study, 14 candidate differentially expressed circRNAs (DECs) between normal thyroid tissues and benign thyroid tissues or PTC were first screened using the GSE93522 dataset by the GEO2R online tool. Then, the structural loop graphs of these 14 circRNAs were obtained through the CSCD database. After performing miRNA co-prediction by combination of CSCD and CRI databases, a potential circRNA-miRNA sub-network, consisting of 9 circRNAs and 21 miRNAs, was successfully constructed. Subsequently, the expression and prognostic values of these miRNAs were further determined by starBase, and two miRNAs, namely, miR-605-5p and miR-876-3p, were identified as key miRNAs in PTC. Then, their downstream target genes were predicted by the miRNet database. CTNNB1 and CCND1 were found to be two most potential targets of miR-876-3p by combination of multiple analyses, including protein-protein interaction (PPI), hub gene screening, correlation analysis, and expression analysis. Conclusively, we established a key hsa_circ_0088494-miR-876-3p-CTNNB1/CCND1 axis linked to carcinogenesis and progression of PTC, which may provide promising therapeutic targets in treating PTC in the future.

Citing Articles

Circular RNAs in cancer.

Guo Y, Huang Q, Heng Y, Zhou Y, Chen H, Xu C MedComm (2020). 2025; 6(2):e70079.

PMID: 39901896 PMC: 11788016. DOI: 10.1002/mco2.70079.


miR-542-3p/PIK3R1 axis is involved in hsa_circ_0087104-mediated inhibition of esophageal squamous cell carcinoma metastasis.

Gao S, Lou W Am J Cancer Res. 2025; 14(12):5665-5679.

PMID: 39803650 PMC: 11711534. DOI: 10.62347/EFEO7205.


Multi-omics analysis of Prolyl 3-hydroxylase 1 as a prognostic biomarker for immune infiltration in ccRCC.

Ding G, Wang T, Sun F, Liu M, Tang G, Yu S NPJ Precis Oncol. 2024; 8(1):256.

PMID: 39516330 PMC: 11549470. DOI: 10.1038/s41698-024-00748-x.


Identification of SLC31A1 as a prognostic biomarker and a target for therapeutics in breast cancer.

Fu H, Dong S, Li K Sci Rep. 2024; 14(1):25120.

PMID: 39448672 PMC: 11502855. DOI: 10.1038/s41598-024-76162-x.


MicroRNAs in thyroid cancer with focus on medullary thyroid carcinoma: potential therapeutic targets and diagnostic/prognostic markers and web based tools.

Shakiba E, Boroomand S, Kheradmand Kia S, Hedayati M Oncol Res. 2024; 32(6):1011-1019.

PMID: 38827323 PMC: 11136686. DOI: 10.32604/or.2024.049235.


References
1.
Dudekula D, Panda A, Grammatikakis I, De S, Abdelmohsen K, Gorospe M . CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2015; 13(1):34-42. PMC: 4829301. DOI: 10.1080/15476286.2015.1128065. View

2.
Fan Y, Xia J . miRNet-Functional Analysis and Visual Exploration of miRNA-Target Interactions in a Network Context. Methods Mol Biol. 2018; 1819:215-233. DOI: 10.1007/978-1-4939-8618-7_10. View

3.
Zhitnyak I, Rubtsova S, Litovka N, Gloushankova N . Early Events in Actin Cytoskeleton Dynamics and E-Cadherin-Mediated Cell-Cell Adhesion during Epithelial-Mesenchymal Transition. Cells. 2020; 9(3). PMC: 7140442. DOI: 10.3390/cells9030578. View

4.
Lu R, Zhang X, Li X, Wan X . Circ_0016418 promotes melanoma development and glutamine catabolism by regulating the miR-605-5p/GLS axis. Int J Clin Exp Pathol. 2020; 13(7):1791-1801. PMC: 7414495. View

5.
Xia S, Feng J, Chen K, Ma Y, Gong J, Cai F . CSCD: a database for cancer-specific circular RNAs. Nucleic Acids Res. 2017; 46(D1):D925-D929. PMC: 5753219. DOI: 10.1093/nar/gkx863. View